Research Insights

Subthalamic nucleus stimulation in Parkinson’s disease: Clinical evaluation of 18 patients

Thobois, S., Mertens, P., Guenot, M., Hermier, M., Mollion, H., Bouvard, M., Chazot, G., Broussolle, E., Sindou, M. (2002) Subthalamic nucleus stimulation in Parkinson’s disease: Clinical evaluation of 18 patients , 249, 529-524

Eighteen consecutive severely affected PD patients were evaluated clinically before and 6 months after the DBS-STN. Additionally, a 12 months follow-up was available in 14 patients. This study confirms the great value of subthalamic nucleus stimulation in the treatment of intractable PD. However, some individuals experienced episodes of depression following surgical procedures. Consequently, some adverse events, including depression, may be taken into account in the inclusion criteria and also in the post-operative outcome.

Click here to read the abstract.

Back

Follow Us Follow us on TwitterFollow us on FacebookInstagram

Sign Up for Email Alerts

By providing your email you agree to receive periodic emails from The Parkinson Alliance.

Please tell us more about yourself:

This month is? (Anti-Spam)

Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2018 The Parkinson Alliance. All rights reserved.